Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma-Moebius Medical announce dual publications on symptomatic knee osteoarthritis treatment MM-II in Osteoarthritis and Cartilage

Written By Ruchika Sharma24 April 2025 12:21 PM IST

The two publications offer complementary insights into MM-II's clinical efficacy and mechanism of action, underscoring its potential therapeutic...

Lupin Launches Dasatinib in US Market in Partnership with Pharmascience

Lupin gets green light from USFDA for kidney drug Tolvaptan

Written By Ruchika Sharma24 April 2025 11:52 AM IST

Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...

Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing Issue

Lupin recalls over 2000 bottles of antidepressant medication in US

Written By Ruchika Sharma23 April 2025 3:09 PM IST

US: Lupin Pharmaceuticals Inc, a US-based subsidiary of Mumbai-headquartered Lupin is recalling over 2000 bottles of an antidepressant...

Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle Disorders

Aurobindo Pharma arm Eugia Pharma Specialities gets USFDA nod for cancer drug

Written By Ruchika Sharma23 April 2025 12:53 PM IST

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval...

USFDA nod to Caplin Steriles Linezolid Injection to treat serious bacterial infections

Caplin Steriles bags USFDA approval for generic therapeutic equivalent version of VITAMIN K1 Injection

Written By Ruchika Sharma23 April 2025 12:27 PM IST

Chennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has received final approval from the...

Trodelvy plus Keytruda effective for aggressive breast cancer type: Gilead Sciences

Written By Ruchika Sharma23 April 2025 10:30 AM IST

Foster City: Gilead Sciences, Inc. has announced positive topline results from the Phase 3 ASCENT-04/KEYNOTE-D19 study, demonstrating that...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic gets USFDA nod for Simplera Sync sensor for MiniMed 780G System

Written By Ruchika Sharma21 April 2025 11:30 AM IST

Medtronic plc has announced the U.S. Food and Drug Administration (FDA) has approved the Simplera Sync sensor for use with the MiniMed 780G...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA grants QIDP Designation to Venus Remedies Novel Polymyxin B Formulation

Written By Ruchika Sharma20 April 2025 3:30 PM IST

Mumbai: Venus Remedies Limited, a pharmaceutical company specializing in critical care injectables, has announced that its investigational...

$GSK Blenrep combos receive positive EMA Committee opinion in relapsed/refractory multiple myeloma$

GSK Blenrep combinations approved by UK MHRA in relapsed/refractory multiple myeloma

Written By Ruchika Sharma20 April 2025 10:00 AM IST

GSK plc has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Blenrep. In the UK, Blenrep is...

GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices

Written By Ruchika Sharma20 April 2025 9:00 AM IST

GSK plc has announced that the Advisory Committee on Immunization Practices (ACIP) voted in favour of recommending the use of RSV vaccines including...

Cadila Pharma appoints Hemant Kumar as President - Supply Chain & Procurement

Written By Ruchika Sharma19 April 2025 2:22 PM IST

Cadila Pharma has appointed Hemant Kumar as President - Supply Chain & Procurement at the company.Hemant shared the update via LinkedIn, stating,...

Aarti Pharmalabs Gets Single Observation in USFDA Inspection at Tarapur Unit

Sanofi, Regeneron Pharma secures USFDA approval for Dupixent for chronic spontaneous urticaria

Written By Ruchika Sharma19 April 2025 1:15 PM IST

Paris: Sanofi and Regeneron Pharma have received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok